Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/7957
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | King, J. | - |
dc.contributor.author | Flenady, V. | - |
dc.contributor.author | Papatsonis, D. | - |
dc.contributor.author | Dekker, G. | - |
dc.contributor.author | Carbonne, B. | - |
dc.date.issued | 2003 | - |
dc.identifier.citation | Australian and New Zealand Journal of Obstetrics and Gynaecology, 2003; 43(3):192-198 | - |
dc.identifier.issn | 0004-8666 | - |
dc.identifier.issn | 1479-828X | - |
dc.identifier.uri | http://hdl.handle.net/2440/7957 | - |
dc.description | The definitive version is available at www.blackwell-synergy.com | - |
dc.description.abstract | Objective: To assess the effects on maternal, fetal and neonatal outcomes of nifedipine (and other calcium channel blockers) administered as a tocolytic agent to women in preterm labour. Methods: Standard methods of the Cochrane Collaboration and its Pregnancy and Childbirth Review Group were used. All published and unpublished randomised trials in which calcium channel blockers were used for tocolysis for women in preterm labour between 20 and 36 weeks’ gestation, were considered. Main results: The systematic review includes 12 randomised controlled trials with a total of 1029 participating women. No trials were identified in which calcium channel blockers were compared with a placebo or no alternative tocolytic treatment. Calcium channel blockers appear to be more effective than betamimetic agents in prolonging pregnancy for 7 days or longer, are much less likely to cause maternal side-effects and are associated with reduced neonatal morbidity. Conclusion: Calcium channel blockers (especially nifedipine) can be considered safer and more effective tocolytic agents than betamimetics. | - |
dc.description.statementofresponsibility | James F. King, Vicki Flenady, Dimitri Papatsonis, Gustaaf Dekker, Bruno Carbonne | - |
dc.language.iso | en | - |
dc.publisher | Australian NZ J Obstet Gynaec | - |
dc.source.uri | http://dx.doi.org/10.1046/j.0004-8666.2003.00074.x | - |
dc.subject | Humans | - |
dc.subject | Nifedipine | - |
dc.subject | Calcium Channel Blockers | - |
dc.subject | Placebos | - |
dc.subject | Pregnancy Outcome | - |
dc.subject | Clinical Protocols | - |
dc.subject | Pregnancy | - |
dc.subject | Female | - |
dc.subject | Obstetric Labor, Premature | - |
dc.subject | Randomized Controlled Trials as Topic | - |
dc.subject | Contraindications | - |
dc.subject | Systematic Reviews as Topic | - |
dc.title | Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1046/j.0004-8666.2003.00074.x | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Dekker, G. [0000-0002-7362-6683] | - |
Appears in Collections: | Aurora harvest Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.